Darzalex Faspro ® is a subcutaneous formulation that combines daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase that increases permeability of the subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback